#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arterial disorder Wiskott-Aldrich syndrome Neoplasm malignant Erythema multiforme Partial lipodystrophy Giant cell tumour of tendon sheath Myeloid leukaemia Pemphigoid Epidermolysis bullosa Retinoblastoma Duchenne muscular dystrophy gene carrier Metastases to peritoneum Deafness T-cell lymphoma Hyperadrenocorticism More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Basic Information Lymphatic malformation – Diagnostics Ewing’s sarcoma recurrent – Life with Disease Brain stem glioma – Trials in Disease Sarcoidosis – Diagnostics Congenital nephrogenic diabetes insipidus – Life with Disease Rett syndrome – Basic Information Acquired haemophilia – Basic Information Wiskott-Aldrich syndrome – Diagnostics Cystic fibrosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Etamsylate Metformin Roginolisib Camonsertib Oxycodone Hydrochloride Tazobactam Sodium Vobramitamab Duocarmazine Ropivacaine Hydrochloride Letetresgene Autoleucel HYALURONIDASE SOFTISAN 378 Azd5462 PIROXICAM Patritumab Deruxtecan Ltp001 Atomoxetine Hydrochloride Florbetapir (18F) Diacerein M2Rlab Aaa802 More therapies…

    Learn about Your Condition

    Allergic respiratory disease Papulopustular rosacea Prodromal Alzheimer's disease Amnestic disorder Renal failure Pain Leukocyte adhesion deficiency Combined immunodeficiency Uterine leiomyosarcoma Pemphigus Mucopolysaccharidosis I Urethral stenosis Haemoptysis Eosinophilic oesophagitis Skin ulcer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic scleroderma

  • Study on the Safety of MB-CART19.1 for Patients with Active Systemic Lupus Erythematosus, Systemic Sclerosis, or Dermatomyositis/Polymyositis

    Recruiting

    1 1 1
    Investigated Diseases:
    • Idiopathic inflammatory myopathy
    • Systemic scleroderma
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    Germany

  • Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    Austria Belgium Czechia Denmark France Germany +5

  • Study on the Safety of Allogeneic Adipose-Derived Mesenchymal Stromal Cells for Patients with Severe Systemic Sclerosis

    Recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Allogeneic Adipose-Derived Mesenchymal Stromal Cells, Ex-Vivo Expanded
    France

  • Study on the Effects of Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease

    Recruiting

    4 1 1
    Investigated Diseases:
    • Interstitial lung disease
    • Systemic scleroderma
    Investigated Drugs:
    • Belimumab
    Belgium Denmark Finland France Germany Greece +2

  • Study on Treating Calcinosis Cutis in Systemic Sclerosis Patients with Sodium Thiosulfate, Cetrimide, and Lidocaine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Cetrimide
    • Sodium Thiosulfate
    • Lidocaine
    Denmark

  • Study on the Use of Allogenic Adipose-Tissue-Derived Mesenchymal Stem Cells for Healing Chronic Digital Ulcers in Systemic Sclerosis Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    France
Previous Page
1 2 3 4 5 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!